Stay updated with breaking news from Oncotype Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Exact Sciences (NASDAQ:EXAS – Get Rating) was downgraded by StockNews.com from a “hold” rating to a “sell” rating in a report released on Friday. Several other equities analysts have also recently weighed in on the company. Raymond James decreased their price objective on Exact Sciences from $90.00 to $80.00 in a report on Wednesday, April […]
PotNetwork (OTCMKTS:POTN – Get Rating) and Exact Sciences (NASDAQ:EXAS – Get Rating) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, risk, earnings, profitability, valuation, dividends and institutional ownership. Analyst Ratings This is a summary of current ratings and target […]
Equities analysts forecast that Exact Sciences Co. (NASDAQ:EXAS – Get Rating) will report sales of $498.48 million for the current fiscal quarter, Zacks Investment Research reports. Seven analysts have issued estimates for Exact Sciences’ earnings, with the lowest sales estimate coming in at $492.40 million and the highest estimate coming in at $505.50 million. Exact […]
MDxHealth (NASDAQ:MDXH – Get Rating) and Exact Sciences (NASDAQ:EXAS – Get Rating) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, risk, institutional ownership, dividends, profitability and earnings. Profitability This table compares MDxHealth and Exact Sciences’ net margins, return […]
Analysts expect that Exact Sciences Co. (NASDAQ:EXAS – Get Rating) will post sales of $461.86 million for the current quarter, Zacks Investment Research reports. Seven analysts have made estimates for Exact Sciences’ earnings, with estimates ranging from $458.10 million to $466.90 million. Exact Sciences reported sales of $402.08 million during the same quarter last year, […]